Asan Medical center

Phase [desc]	Trial	Trial Status	Site Status	Drug	NCT#
1	Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors	Withdrawn	Not yet activated	Imatinib + Dovitinib	NCT02268435
1	A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors	Ongoing, but not recruiting	Closed	Cobimetinib + MPDL3280A	NCT01988896
1	(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors	Active, not recruiting	Closed	BLU-285	NCT02508532
1	A Study of NB003 in Patients With Advanced Malignancies	Active, not recruiting	Active	NB003	NCT04936178
1	A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST1]	Recruiting	Active	IDRX-42	NCT05489237
	Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST)	Completed	Closed	Nilotinib	NCT00976612